about
Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide.The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago.Intra-arterial administration of tumor-targeting Salmonella typhimurium A1-R regresses a cisplatin-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) model.Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patients.Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: Decoy, trap and kill chRegorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 in a patient-derived orthotopic xenograft (PDOX) nude mouse model.A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue SarcomaPatterns of sensitivity to a panel of drugs are highly individualised for undifferentiated/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse modelsTreatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRI
P50
Q46020823-E605CB57-0A51-4CF2-8B48-8E5746149984Q46314062-822C472B-D3D3-4604-8248-5BD5E8EB8853Q46326758-25CF852C-92FE-40F7-A672-25A48F3B70C3Q46341637-93BD7398-7547-417C-AE0F-8D93C2E3629FQ46560568-40102B93-4F8F-4D12-A2E9-9A645493B94EQ48135854-16EE15E6-160E-47FD-BB67-B695258F6095Q48156221-25B66642-9149-427B-B518-EDD1C3E10613Q48243511-CE5AF3AD-5539-4757-B90B-E5B9B7720A72Q89700798-53A76833-D29C-49E5-B9F2-9102C3F0175CQ90338064-BB0A2820-FA8C-431D-BAFA-980C0274263BQ96591733-A0C304BE-D496-4910-BB1A-FAA789193C72
P50
description
researcher
@en
wetenschapper
@nl
name
Fritz C Eilber
@en
Fritz C Eilber
@nl
type
label
Fritz C Eilber
@en
Fritz C Eilber
@nl
prefLabel
Fritz C Eilber
@en
Fritz C Eilber
@nl
P31
P496
0000-0003-3336-9333